Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).
This position statement was prepared by the European Council of Nuclear Cardiology and summarises the current and future potential of PET as a clinical cardiovascular diagnostic imaging tool. The first section describes how methodological developments have positively influenced the transition of PET from a research tool towards a clinical diagnostic test. In the second section, evidence in support of its superior diagnostic accuracy, its value to guide decision making and to predict outcome and its cost effectiveness is summarised. The third section finally outlines new PET-based approaches and concepts, which will likely influence clinical cardiovascular medicine in the future. The notion that integration of cardiac PET into healthcare systems and disease management algorithms will advance quality of care is increasingly supported by the literature highlighted in this statement.
Le Guludec
D
D
Department of Nuclear Medicine, Bichat Hospital, Paris, France. ecnc-office@vereint.com
Lautamäki
R
R
Knuuti
J
J
Bax
J J
JJ
Bengel
F M
FM
D002309:Cardiology; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging*; D005060:Europe; D006801:Humans; D009683:Nuclear Medicine; D049268:Positron-Emission Tomography / Q000191:economics / Q000379:methods* / Q000639:trends*; D012955:Societies, Medical